News: Research
New Drug Has Potential to Protect Brain Cells from Traumatic Injuries
Stephen Martin and James Sahn have demonstrated that a new compound protects brain cells in mice that have been subjected to brain trauma, raising the prospects of a possible treatment for humans who experience TBI.
Making Cancer’s Metabolism More Normal Blocks Drug Resistance
A new combination of existing drugs reduces the size of cancerous tumors much more effectively than current treatments.
New Material Could Save Time and Money in Medical Imaging and Environmental Remediation
Chemists at UT Austin have developed a material that holds the key to cheap, fast and portable new sensors for a wide range of chemicals.
Chemists Garner New Insights into Protein Linked to Alzheimer’s Disease
A mutation in a normal protein can create amyloid β, a key contributor to Alzheimer's disease, researchers have found.
Drug Engineered at UT Austin to Treat Anthrax Gains FDA Approval
The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).
When Sperm Meets Egg, Zinc 'Fireworks' on Display
The University of Texas at Austin's Emily Que, an assistant professor of chemistry, was lead author on a new study that describes the cutting-edge technology a research team used to become the first to capture images of these molecular fireworks and to pinpoint the origin of the zinc sparks.
UT News
Synthetic Molecule Makes Cancer Self-Destruct
Researchers from The University of Texas at Austin and five other institutions have created a molecule that can cause cancer cells to self-destruct by ferrying sodium and chloride ions into the cancer cells.
